Murray Aitken

IMS Institute for Healthcare Informatics

100 IMS Drive

Parsippany, NJ 07054

United States

  • IMS Institute for Healthcare Informatics

SCHOLARLY PAPERS

4

DOWNLOADS
Rank 32,210

SSRN RANKINGS

Top 32,210

in Total Papers Downloads

2,161

SSRN CITATIONS
Rank 29,636

SSRN RANKINGS

Top 29,636

in Total Papers Citations

4

CROSSREF CITATIONS

25

Scholarly Papers (4)

Actions:
Email selected abstracts
1.

Advancing the Responsible Use of Medicines: Applying Levers for Change

Number of pages: 220 Posted: 23 Feb 2013
Murray Aitken and Lyudmila Gorokhovich
IMS Institute for Healthcare Informatics and IMS Institute for Healthcare Informatics
Downloads 1,968 (11,483)
Citation 24

Abstract:

Loading...

responsible medicine use, medicines, adherence, medication errors, antibiotics, healthcare system, pharmaceuticals, costs

2.

Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century after the 1984 Waxman-Hatch Legislation

NBER Working Paper No. w16431
Number of pages: 29 Posted: 12 Oct 2010 Last Revised: 26 May 2022
Ernst R. Berndt and Murray Aitken
Massachusetts Institute of Technology (MIT) - Sloan School of Management and IMS Institute for Healthcare Informatics
Downloads 95 (370,739)
Citation 4

Abstract:

Loading...

3.

The Regulation of Prescription Drug Competition and Market Responses: Patterns in Prices and Sales Following Loss of Exclusivity

NBER Working Paper No. w19487
Number of pages: 39 Posted: 05 Oct 2013 Last Revised: 01 Apr 2022
Murray Aitken, Ernst R. Berndt, Barry Bosworth, Iain M. Cockburn, Richard G. Frank, Michael Kleinrock and Bradley Shapiro
IMS Institute for Healthcare Informatics, Massachusetts Institute of Technology (MIT) - Sloan School of Management, Brookings Institution - Economic Studies Program, Boston University Questrom School of Business, Harvard Medical School, IMS Institute for Healthcare Informatics and University of Chicago - Booth School of Business
Downloads 57 (490,323)

Abstract:

Loading...

4.

Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?

NBER Working Paper No. w16014
Number of pages: 48 Posted: 04 Jun 2010 Last Revised: 04 Apr 2022
Mark R. Trusheim, Murray Aitken and Ernst R. Berndt
Massachusetts Institute of Technology (MIT) - Sloan School of Management, IMS Institute for Healthcare Informatics and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 41 (561,986)

Abstract:

Loading...

Other Papers (1)

Total Downloads: 7
Actions:
Email selected abstracts
1.

Characterizing Markets for Biopharmaceutical Innovations: Do Biologics Differ from Small Molecules?

Forum for Health Economics & Policy, Vol. 13: Issue 1, American Society of Health Economists (ASHEcon) Paper
Number of pages: 45 Posted: 07 Jul 2011 Last Revised: 27 Oct 2011
Mark R. Trusheim, Murray Aitken and Ernst R. Berndt
Massachusetts Institute of Technology (MIT) - Sloan School of Management, IMS Institute for Healthcare Informatics and Massachusetts Institute of Technology (MIT) - Sloan School of Management
Downloads 7

Abstract:

Loading...

biologic, pharmaceutical, price